Tag: Benlysta

FDA, Regulations

GSK’s Benlysta given orphan drug status by FDA for systemic sclerosis

February 1, 2023


The antibody will now benefit from the incentives given to those drugs granted orphan status through the FDA’s ODD programme, introduced by the organisation to improve the availability of treatments for rare diseases. Affecting two to ten people per million, […]